- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bolt Biotherapeutics (BOLT)
Bolt Biotherapeutics stock price live, this page displays NASDAQ BOLT stock exchange data. View the BOLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bolt Biotherapeutics real time stock price chart below.
What Is the Bolt Biotherapeutics Stock Price Today?
The Bolt Biotherapeutics stock price today is 3.665.
What Is the Stock Symbol for Bolt Biotherapeutics?
The stock symbol for Bolt Biotherapeutics is "BOLT."
What Stock Exchange Does Bolt Biotherapeutics Trade On?
Bolt Biotherapeutics is listed and trades on the NASDAQ stock exchange.
Is Bolt Biotherapeutics a Good Stock to Buy?
Determining whether Bolt Biotherapeutics, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOLT quote. (ISIN: US0977022039)
What Is the Bolt Biotherapeutics Stock Price Today?
The Bolt Biotherapeutics stock price today is 3.665.
What Is the Stock Symbol for Bolt Biotherapeutics?
The stock symbol for Bolt Biotherapeutics is "BOLT."
What Stock Exchange Does Bolt Biotherapeutics Trade On?
Bolt Biotherapeutics is listed and trades on the NASDAQ stock exchange.
Is Bolt Biotherapeutics a Good Stock to Buy?
Determining whether Bolt Biotherapeutics, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOLT quote. (ISIN: US0977022039)
NASDAQ
Currency in USD
Fair Value
An estimate of a Bolt's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.202
3.780
52 wk Range
3.130
7.200
Unusual trading volume
1/2
Fair Value
An estimate of a Bolt's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2023.780
52 wk Range
3.1307.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BOLT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bolt's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
29.000
Upside
+691.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 4 Bolt Biotherapeutics For: 11 June- Investing.com
Form 13G Bolt Biotherapeutics For: 13 February- Investing.com
- Form 4 Bolt Biotherapeutics For: 11 June
- Investing.com
Form DEF 14A Bolt Biotherapeutics For: 28 April- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.000
(+691.27% Upside)
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
-4.57 / -3.33
Revenue / Forecast
5K / 1.5M
Compare BOLT to Peers and Sector
Metrics to compare | BOLT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBOLTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −1.7x | −0.4x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | 0.6x | 2.6x | 2.6x | |
Price / LTM Sales | 1.5x | 11.6x | 3.1x | |
Upside (Analyst Target) | 91.0% | 143.9% | 48.9% | |
Fair Value Upside | Unlock | 10.8% | 6.2% | Unlock |
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bolt (BOLT) Stock Price Today?
The Bolt stock price today is 3.665 USD.
What Stock Exchange Does Bolt Trade On?
Bolt is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Bolt?
The stock symbol for Bolt is "BOLT."
What Is the Bolt (BOLT) Afterhours Price Today? (Afterhours variable test: 3.668) Current Date: Aug 23, 2026
After hours price: 3.668. After hours price change (units): 0.003. Price change percentage: 0.070%
What Is the Bolt Market Cap?
As of today, Bolt market cap is 7.060M USD.
What Is Bolt's Earnings Per Share (TTM)?
The Bolt EPS (TTM) is -16.385.
When Is the Next Bolt Earnings Date?
Bolt will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is BOLT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Bolt Stock Split?
Bolt has split 1 times.
How Many Employees Does Bolt Have?
Bolt has 23 employees.
What is the current trading status of Bolt (BOLT)?
As of Aug 23, 2026, Bolt (BOLT) is trading at a price of 3.665 USD, with a previous close of 3.200 USD. The stock has fluctuated within a day range of 3.202 USD to 3.780 USD, while its 52-week range spans from 3.130 USD to 7.200 USD.
What Is Bolt (BOLT) Price Target According to Analysts?
The average 12-month price target for Bolt is 29.000 USD, with a high estimate of 75 USD and a low estimate of 5 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +691.27% Upside potential.
What Is the BOLT After Hours Price?
BOLT's last after hours stock price is 3.668 USD, the stock has decreased by 0.003, or 0.070%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.